Calfactant for Direct Acute Respiratory Distress Syndrome
Status:
Terminated
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
This study will determine if administration of an suspension of calfactant, a lung
surfactant, intratracheally in patients with Direct Acute Respiratory Distress Syndrome
within 48 hours of requiring mechanical ventilation can decrease the mortality in patients
with lethal disease and shorten the course of respiratory failure in patients with sub-lethal
disease.